Atique U. Ahmed

Department of Neurological Surgery, Northwestern University

Research Area

Biography

Atique U. Ahmed has not added Biography.
If you are Atique U. Ahmed and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2025

Other Publications

Article	Year
Stem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open Questions. Viruses\| PubMed ID: 26633462	2015
Single dose GLP toxicity and biodistribution study of a conditionally replicative adenovirus vector, CRAd-S-pk7, administered by intracerebral injection to Syrian hamsters. Journal of translational medicine\| PubMed ID: 27184224	2016
Dogs are man's best friend: in sickness and in health. Neuro-oncology\| PubMed ID: 27298310	2017
CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells. Cancer research\| PubMed ID: 27530322	2016
Intranasal Oncolytic Virotherapy with CXCR4-Enhanced Stem Cells Extends Survival in Mouse Model of Glioma. Stem cell reports\| PubMed ID: 27594591	2016
Dedifferentiation of Glioma Cells to Glioma Stem-like Cells By Therapeutic Stress-induced HIF Signaling in the Recurrent GBM Model. Molecular cancer therapeutics\| PubMed ID: 27765847	2016
Cancer Stem Cells: Cellular Plasticity, Niche, and its Clinical Relevance. Journal of stem cell research & therapy\| PubMed ID: 27891292	2016
Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 28696296	2017
Monoamines in glioblastoma: complex biology with therapeutic potential. Neuro-oncology\| PubMed ID: 29126252	2018
A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor Model. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics\| PubMed ID: 30027430	2018
Activation of Dopamine Receptor 2 Prompts Transcriptomic and Metabolic Plasticity in Glioblastoma. The Journal of neuroscience : the official journal of the Society for Neuroscience\| PubMed ID: 30651332	2019
Rogue one: another faction of the Wnt empire implicated in assisting GBM progression. Translational cancer research\| PubMed ID: 30662831	2017
Glioblastoma Recurrence and the Role of O-Methylguanine-DNA Methyltransferase Promoter Methylation. JCO clinical cancer informatics\| PubMed ID: 30758983	2019
Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma. Cell death & disease\| PubMed ID: 30926789	2019
HIF-1α Is a Metabolic Switch between Glycolytic-Driven Migration and Oxidative Phosphorylation-Driven Immunosuppression of Tregs in Glioblastoma. Cell reports\| PubMed ID: 30943404	2019
Diagnostic Clinical Trials in Breast Cancer Brain Metastases: Barriers and Innovations. Clinical breast cancer\| PubMed ID: 31262686	2019
Chemotherapeutic Stress Induces Transdifferentiation of Glioblastoma Cells to Endothelial Cells and Promotes Vascular Mimicry. Stem cells international\| PubMed ID: 31316566	2019
FABP7 is a key metabolic regulator in HER2+ breast cancer brain metastasis. Oncogene\| PubMed ID: 31324889	2019
Current state of clinical trials in breast cancer brain metastases. Neuro-oncology practice\| PubMed ID: 31555454	2019
BET inhibition increases βIII-tubulin expression and sensitizes metastatic breast cancer in the brain to vinorelbine. Science translational medicine\| PubMed ID: 32848091	2020
Separate and not equal: sex differences in JAM-A tumor suppression in glioblastoma. Neuro-oncology\| PubMed ID: 32960216	2020
Temozolomide Treatment Increases Fatty Acid Uptake in Glioblastoma Stem Cells. Cancers\| PubMed ID: 33114573	2020
Molecular Classification of Gliomas is Associated with Seizure Control: A Retrospective Analysis. Neuromolecular medicine\| PubMed ID: 33206320	2021
LNX1 Modulates Notch1 Signaling to Promote Expansion of the Glioma Stem Cell Population during Temozolomide Therapy in Glioblastoma. Cancers\| PubMed ID: 33255632	2020
De novo purine biosynthesis is a major driver of chemoresistance in glioblastoma. Brain : a journal of neurology\| PubMed ID: 33855339	2021
Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial. The Lancet. Oncology\| PubMed ID: 34214495	2021
Spelling Out CICs: A Multi-Organ Examination of the Contributions of Cancer Initiating Cells' Role in Tumor Progression. Stem cell reviews and reports\| PubMed ID: 34244971	2022
Combination of tucatinib and neural stem cells secreting anti-HER2 antibody prolongs survival of mice with metastatic brain cancer. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 34969858	2022
Checkpoint: Inspecting the barriers in glioblastoma immunotherapies. Seminars in cancer biology\| PubMed ID: 35150865	2022
Circadian Regulator CLOCK Drives Immunosuppression in Glioblastoma. Cancer immunology research\| PubMed ID: 35413115	2022
Translocon-associated Protein Subunit SSR3 Determines and Predicts Susceptibility to Paclitaxel in Breast Cancer and Glioblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 35552677	2022
Endoplasmic Reticulum Stress in the Brain Tumor Immune Microenvironment. Molecular cancer research : MCR\| PubMed ID: 36652630	2023
Genomic Analysis of Human Brain Metastases Treated with Stereotactic Radiosurgery Under the Phase-II Clinical Trial (NCT03398694) Reveals DNA Damage Repair at the Peripheral Tumor Edge. medRxiv : the preprint server for health sciences\| PubMed ID: 37131583	2023
Ribonucleotide reductase regulatory subunit M2 drives glioblastoma TMZ resistance through modulation of dNTP production. Science advances\| PubMed ID: 37196077	2023
Metixene is an incomplete autophagy inducer in preclinical models of metastatic cancer and brain metastases. The Journal of clinical investigation\| PubMed ID: 37847564	2023
Myeloid cell-derived creatine in the hypoxic niche promotes glioblastoma growth. Cell metabolism\| PubMed ID: 38134929	2024
ARF4-mediated retrograde trafficking as a driver of chemoresistance in glioblastoma. Neuro-oncology\| PubMed ID: 38506351	2024
Genomic analysis of human brain metastases treated with stereotactic radiosurgery reveals unique signature based on treatment failure. iScience\| PubMed ID: 38623341	2024
B cell-based therapy produces antibodies that inhibit glioblastoma growth. The Journal of clinical investigation\| PubMed ID: 39207859	2024
A covalent creatine kinase inhibitor ablates glioblastoma migration and sensitizes tumors to oxidative stress. Scientific reports\| PubMed ID: 39304717	2024
Beyond the brain: exploring the impact of animal models of leptomeningeal disease from solid tumors. Acta neuropathologica communications\| PubMed ID: 40383789	2025
LMNA-PRKDC axis enhances DNA repair and promotes chemoresistance in glioblastoma. Cell death & disease\| PubMed ID: 41271669	2025